BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32776998)

  • 1. Breast Cancer Screening and Health Care Costs.
    Heller SL; Moy L
    JAMA Intern Med; 2020 Nov; 180(11):1552-1553. PubMed ID: 32776998
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast Cancer Screening and Health Care Costs.
    Grimm LJ
    JAMA Intern Med; 2020 Nov; 180(11):1552. PubMed ID: 32776997
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast Cancer Screening and Health Care Costs-Reply.
    Kunst N; Gross CP
    JAMA Intern Med; 2020 Nov; 180(11):1553-1554. PubMed ID: 32777026
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The patient burden of screening mammography recall.
    Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in Norway.
    Moger TA; Swanson JO; Holen ÅS; Hanestad B; Hofvind S
    Eur J Health Econ; 2019 Nov; 20(8):1261-1269. PubMed ID: 31399773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort.
    Saxby K; Nickson C; Mann GB; Velentzis L; Bromley HL; Procopio P; Canfell K; Petrie D
    Aust N Z J Public Health; 2020 Jun; 44(3):219-226. PubMed ID: 32311194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Screening for breast cancer: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2009 Nov; 151(10):I44. PubMed ID: 19920254
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
    Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography Screening Uptake among Female Health Care Workers in Primary Health Care Centers in Palestine - Motivators and Barriers.
    Nazzal Z; Sholi H; Sholi S; Sholi M; Lahaseh R
    Asian Pac J Cancer Prev; 2016; 17(5):2549-54. PubMed ID: 27268628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models.
    Fleming MM; Hughes DR; Golding LP; McGinty GB; MacFarlane D; Duszak R
    J Am Coll Radiol; 2019 Jul; 16(7):902-907. PubMed ID: 30679104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic screening for breast cancer: 2010.
    Margolies L
    Mt Sinai J Med; 2010; 77(4):398-404. PubMed ID: 20687187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast density: the trend in breast cancer screening.
    Machida Y; Tozaki M; Shimauchi A; Yoshida T
    Breast Cancer; 2015 May; 22(3):253-61. PubMed ID: 25784189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.
    Manjelievskaia J; Brown D; Shao S; Hofmann K; Shriver CD; Zhu K
    Mil Med; 2017 Mar; 182(3):e1782-e1789. PubMed ID: 28290959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.